[go: up one dir, main page]

UA100531C2 - Antigen binding proteins capable of binding thymic stromal lymphopoietin - Google Patents

Antigen binding proteins capable of binding thymic stromal lymphopoietin

Info

Publication number
UA100531C2
UA100531C2 UAA201004253A UAA201004253A UA100531C2 UA 100531 C2 UA100531 C2 UA 100531C2 UA A201004253 A UAA201004253 A UA A201004253A UA A201004253 A UAA201004253 A UA A201004253A UA 100531 C2 UA100531 C2 UA 100531C2
Authority
UA
Ukraine
Prior art keywords
antibody
thymic stromal
stromal lymphopoietin
proteins capable
binding
Prior art date
Application number
UAA201004253A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Майкл Р. Комю
Джеймс Ф. Смозерс
Бо-рин П. Юн
Кристофер Мехлин
Original Assignee
Амген Инк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амген Инк filed Critical Амген Инк
Priority claimed from PCT/US2008/010510 external-priority patent/WO2009035577A1/en
Publication of UA100531C2 publication Critical patent/UA100531C2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides antibody that specifically binds to human thymic stromal lymphopoietin (TSLP). The invention further relates to an isolated nucleic acid molecule encoding the antibody, recombinant expression vector, host cell, hybridoma, method for producing an antibody, pharmaceutical composition and use of antibody in the preparation of a medicament for treating and preventing TSLP-related inflammatory and fibrotic disorders.
UAA201004253A 2007-09-10 2008-09-09 Antigen binding proteins capable of binding thymic stromal lymphopoietin UA100531C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97117807P 2007-09-10 2007-09-10
PCT/US2008/010510 WO2009035577A1 (en) 2007-09-10 2008-09-09 Antigen binding proteins capable of binding thymic stromal lymphopoietin

Publications (1)

Publication Number Publication Date
UA100531C2 true UA100531C2 (en) 2013-01-10

Family

ID=51583876

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201004253A UA100531C2 (en) 2007-09-10 2008-09-09 Antigen binding proteins capable of binding thymic stromal lymphopoietin

Country Status (2)

Country Link
AR (1) AR110159A2 (en)
UA (1) UA100531C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113501878A (en) * 2021-02-03 2021-10-15 北京智仁美博生物科技有限公司 Antibodies against human TSLP and uses thereof
CN117106084A (en) * 2021-12-02 2023-11-24 北京东方百泰生物科技股份有限公司 An anti-TSLP monoclonal antibody, its antigen-binding fragment and its application

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113501878A (en) * 2021-02-03 2021-10-15 北京智仁美博生物科技有限公司 Antibodies against human TSLP and uses thereof
CN117106084A (en) * 2021-12-02 2023-11-24 北京东方百泰生物科技股份有限公司 An anti-TSLP monoclonal antibody, its antigen-binding fragment and its application
CN117209604A (en) * 2021-12-02 2023-12-12 北京东方百泰生物科技股份有限公司 anti-TSLP monoclonal antibody, antigen binding fragment thereof and application thereof
CN117209604B (en) * 2021-12-02 2024-03-22 北京东方百泰生物科技股份有限公司 An anti-TSLP monoclonal antibody, its antigen-binding fragment and its application
CN117106084B (en) * 2021-12-02 2024-03-22 北京东方百泰生物科技股份有限公司 An anti-TSLP monoclonal antibody, its antigen-binding fragment and its application

Also Published As

Publication number Publication date
AR110159A2 (en) 2019-02-27

Similar Documents

Publication Publication Date Title
JO3351B1 (en) Antigen binding proteins capable of binding thymic stromal lymphopoietin
JOP20190017B1 (en) Human cgrp receptor binding antibodies
TW201129379A (en) Anti-Orai1 antigen binding proteins and uses thereof
BR112012018914A2 (en) "humanized antibody, antigen binding protein, nucleic acid molecule, expression vector, recombinant host cell, antibody or antigen binding protein, methods for producing an antigen binding protein and for treating a subject affected by an autoimmune or inflammatory disease, and, pharmaceutical composition. "
PH12014502527B1 (en) St2 antigen binding proteins
MY162534A (en) Anti-il-6 receptor antibody
EP2352523A4 (en) IMPROVED ANTI-CD19 ANTIBODIES
MX2009013824A (en) Antigen binding proteins that bind par-2.
UA97516C2 (en) Fully human anti-vap-1 monoclonal antibody
WO2010019570A3 (en) Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
EA201500204A1 (en) ANTIBODIES TO OX40 AND METHODS OF THEIR APPLICATION
MX2009003093A (en) Compositions and methods relating to glucagon receptor antibodies.
BR112012004823A8 (en) ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF, USE OF AN ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL COMPOSITION
PH12015500806B1 (en) Binding molecules to the human ox40 receptor
UA100682C2 (en) Antibody which neutralizes human cytomegalovirus (hcmv) and use thereof
MX2011012039A (en) Blocking anti-dkk-1 antibodies and their uses.
AU2009260320A8 (en) Antibodies to IL-6 and their uses
PH12012502193A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
MX2013011706A (en) Novel egfr binding proteins.
WO2010113117A3 (en) Preparation of isolated agonist anti-edar monoclonal antibodies
IN2009CN03372A (en)
UA100531C2 (en) Antigen binding proteins capable of binding thymic stromal lymphopoietin
UA99714C2 (en) Monoclonal antibody that specifically binds to light
MX2024006573A (en) B7-h4 antibodies and anti-b7-h4 antibody/il-15 fusion proteins.
UA97414C2 (en) Human gm-csf antigen binding proteins